Sponsored content by SEVA
Research Joint, Knee & Musculoskeletal Pain
Joint, knee & musculoskeletal pain: what a clinical trial found
A clinical trial published in The Journal of arthroplasty adds to what is known about joint, knee & musculoskeletal pain.
Reporting on an item first published by pubmed.ncbi.nlm.nih.gov. See Sources.
This article is general health information written by our editors from the sources listed below. It has not yet been medically reviewed — see our medical review policy. It is not advice for your situation.
People living with joint, knee & musculoskeletal pain often want to know which treatments are worth considering. A clinical trial published in The Journal of arthroplasty adds to that picture.
Below: what the researchers did, their key results in their own words, and the limits to keep in mind.
Why this question matters
The authors set the scene this way: “This study compared patient-reported outcomes at 24 months after simultaneous Bi-UKA and CR-TKA.”
The work focuses on closer to Native, Not Clinically Superior: Bi-Unicompartmental versus Total Knee Arthroplasty, and on how well these options may help people with joint, knee & musculoskeletal pain.
What the researchers looked at
This clinical trial looked at closer to Native, Not Clinically Superior: Bi-Unicompartmental versus Total Knee Arthroplasty for joint, knee & musculoskeletal pain. It included 26 patients.
A clinical trial tests a treatment in people under a set plan and measures what happens.
The authors describe their approach this way: “Bi-unicompartmental knee arthroplasty (Bi-UKA) has been proposed as an alternative to cruciate-retaining total knee arthroplasty (CR-TKA) for patients who have bicompartmental femoro-tibial osteoarthritis.”
What they found
The authors report: “There was no statistically significant between-group difference observed in the FJS at 24 months (mean difference [Bi-UKA minus CR-TKA], -4.91 points; 95% confidence interval [CI]: -17.92 to 8.09; P = 0.453).”
They also note: “There were no major postoperative complications, reoperations, or revisions documented in either group during the 24-month follow-up.”
Their overall conclusion: “Follow-up beyond 24 months is required to characterize implant durability, revision risk, and survivorship after both procedures.”
What to keep in mind
A single trial usually needs to be confirmed by others before it changes everyday care.
It also notes an important limit: “In this exploratory trial of carefully selected patients who had severe bicompartmental femoro-tibial osteoarthritis, intact ACL and PCL, and absent or minimal patello-femoral involvement, simultaneous Bi-UKA did not demonstrate superior patient-reported outcomes compared with CR-TKA at 24 months.”
What this may mean for people living with joint, knee & musculoskeletal pain
Joint pain often comes from arthritis, an old injury or inflammation of the tissues around a joint.
Research results describe groups of people. How a treatment works for you depends on your diagnosis, other health conditions, medicines and goals, so it is worth discussing any new finding with your own clinician before changing your care.
Movement matters: regular, appropriate exercise and strengthening the muscles around a joint generally reduce pain and stiffness over time, though the right amount depends on your diagnosis.
At SEVA Healthcare, pain specialists offer options for joint, knee and musculoskeletal pain such as Genicular Artery Embolization (GAE), Platelet-Rich Plasma (PRP) Therapy, Stem Cell Therapy and Joint Injections (Knee, Shoulder, Hip), after an individual evaluation.
Getting help with pain
Evaluation usually involves an examination of the joint, a review of how pain affects walking or daily tasks, and X-rays or other imaging when needed.
Pain that does not settle after a few weeks, returns again and again, or gets in the way of sleep, work or family life is worth a specialist’s opinion.
Seek prompt care for a hot, swollen joint with fever, a joint that suddenly cannot bear weight, or a visible deformity after an injury.
- Is this osteoarthritis, an injury, or an inflammatory condition — and how do you know?
- Which exercises are safe for my joint, and should I see a physical therapist?
- What are my options before considering joint replacement, and what does the evidence say about each?
Frequently asked questions
What kind of study is this?
It is a clinical trial published in The Journal of arthroplasty. A clinical trial tests a treatment in people under a set plan and measures what happens.
Does this mean I should try closer to Native, Not Clinically Superior: Bi-Unicompartmental versus Total Knee Arthroplasty?
Not on its own. One clinical trial does not decide what is right for you. Talk with a pain specialist about your diagnosis, other conditions and medicines before starting or stopping any treatment.
Where can I read the original?
The original source is linked under Sources at the end of this article.
Are regenerative treatments right for everyone?
No. Evidence for PRP and stem cell therapy varies by condition, and they are not suitable for every patient. Ask your clinician about the expected benefit, the evidence and the cost.
Sources
This article is sponsored content by SEVA and is for general information only — it is not medical or legal advice. Treatment options depend on an individual evaluation, and results vary from person to person. In an emergency, call 911. Spotted an error? See our corrections policy.
